The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase 2 study of nab-paclitaxel and gemcitabine with or without tocilizumab as first-line treatment in patients with advanced pancreatic cancer (PACTO).
 
Inna Markovna Chen
Consulting or Advisory Role - Amgen; AstraZeneca
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genis (Inst); Roche (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Celgene; Roche
 
Julia S. Johansen
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Celgene; Roche
 
Susann Theile
No Relationships to Disclose
 
Kasper Madsen
No Relationships to Disclose
 
Olav Dajani
No Relationships to Disclose
 
Torben Lorentzen
No Relationships to Disclose
 
Teresa Zimmers
No Relationships to Disclose
 
Dorte Nielsen
No Relationships to Disclose